ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

PRPO Precipio Inc

5,3208
-0,4892 (-8,42%)
19 Juin 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Precipio Inc PRPO NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
-0,4892 -8,42% 5,3208 02:00:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,50 5,28 5,8701 5,3208 5,81
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
13/6/202422:59EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/6/202422:58EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
13/6/202422:00GLOBEPrecipio Inc. Announces Adjournment of Annual Meeting of..
12/6/202422:00GLOBEPrecipio is requesting Shareholders/Brokers vote today to..
12/6/202415:00GLOBEPrecipio Provides Status Update on Current Business Matters
14/5/202422:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202423:20EDGAR2Form 8-K - Current report
06/5/202423:00GLOBEPrecipio Secures a short-term $500K Credit Facility
25/3/202422:00GLOBEPrecipio Announces Year end 2023 Shareholder Update Call
13/2/202416:00GLOBEPrecipio to Report $15.2M for FY-2023 (unaudited) Revenues,..
06/2/202416:00GLOBEPrecipio and Cardinal Health Sign Distribution Agreement for..
23/1/202416:00GLOBEPrecipio’s Q4-2023 Cash Burn From Operations (unaudited)..
19/1/202422:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
17/1/202416:30GLOBEPrecipio Signs Distribution Agreement For IV-Cell® and..
04/1/202422:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:30EDGAR2Form 3 - Initial statement of beneficial ownership of..
02/1/202423:01EDGAR2Form 8-K - Current report
02/1/202415:00GLOBEPrecipio Announces Christina Valauri joins the Board of..
14/12/202323:00EDGAR2Form 8-K - Current report
14/12/202322:30GLOBEPrecipio Management Shares Thoughts on 2023, and Looks Ahead..
16/11/202323:15EDGAR2Form 8-K - Current report
16/11/202323:00GLOBEPrecipio Announces Q3-2023 Shareholder Update Call
13/11/202322:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
31/10/202321:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/10/202322:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/10/202315:00GLOBEPrecipio to Report $4.5M Q3-2023 Revenues, Double From..
06/10/202322:34EDGAR2Form 8-K - Current report
03/10/202316:00GLOBEPrecipio’s Q3 Cash Burn From Operations (unaudited) Declines..
28/9/202315:00GLOBEPrecipio Continues to Sign New HemeScreen™ Customers
25/9/202317:00GLOBEPrecipio Reduces Product Revenue Result Needed for Cash Flow..
21/9/202323:10EDGAR2Form 8-K - Current report
14/9/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/9/202322:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/9/202315:30GLOBEPrecipio’s Pathology Division Exceeds Breakeven Revenues in..
14/8/202322:00EDGAR2Form 8-K - Current report
11/8/202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202323:00GLOBEPrecipio Announces Q2-2023 Shareholder Update Call
08/8/202315:00GLOBEPrecipio Launches Its Much-Anticipated Quantitative BCR-ABL..
03/8/202315:00GLOBEPrecipio’s Operational Efficiency Measures Continue To..
01/8/202315:00GLOBEPrecipio Unaudited Q2-2023 Revenues Show combined increase..
07/7/202322:30EDGAR2Form S-1 - General form for registration of securities under..